News

Survival data from the first prospective, randomized biomarker validation trial in muscle-invasive bladder cancer presented at GU ASCO

Higher toxicity risk for women was known for chemotherapy, now also identified for immunotherapy and targeted therapy

Major financial hardship common after cancer diagnosis, despite insurance